PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1972 | 225 |
| 1973 | 296 |
| 1974 | 319 |
| 1975 | 345 |
| 1976 | 410 |
| 1977 | 414 |
| 1978 | 417 |
| 1979 | 384 |
| 1980 | 425 |
| 1981 | 438 |
| 1982 | 492 |
| 1983 | 441 |
| 1984 | 478 |
| 1985 | 465 |
| 1986 | 518 |
| 1987 | 497 |
| 1988 | 472 |
| 1989 | 510 |
| 1990 | 578 |
| 1991 | 581 |
| 1992 | 607 |
| 1993 | 587 |
| 1994 | 599 |
| 1995 | 576 |
| 1996 | 609 |
| 1997 | 565 |
| 1998 | 665 |
| 1999 | 608 |
| 2000 | 680 |
| 2001 | 669 |
| 2002 | 721 |
| 2003 | 720 |
| 2004 | 827 |
| 2005 | 889 |
| 2006 | 889 |
| 2007 | 764 |
| 2008 | 787 |
| 2009 | 863 |
| 2010 | 861 |
| 2011 | 964 |
| 2012 | 986 |
| 2013 | 1038 |
| 2014 | 1101 |
| 2015 | 1138 |
| 2016 | 906 |
| 2017 | 983 |
| 2018 | 921 |
| 2019 | 812 |
| 2020 | 774 |
| 2021 | 797 |
| 2022 | 427 |
| 2023 | 369 |
| 2024 | 437 |
| 2025 | 437 |
| 2026 | 363 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Antimicrob Agents Chemother"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
In vitro activity of zosurabalpin against a global set of carbapenem-resistant-A. baumannii clinical isolates.
- Mancini S, Seth-Smith HMB, Haldimann K, Moran-Gilad J, Aktas E, Güneş Ö, Mama Hussen M, Willcox M, Shahzad S, Syed MA, Kolesnik-Goldmann N, Roloff T, Nolte O, Egli A.
- Antimicrob Agents Chemother. 2026 Sep 16;70(10):e0072726. doi: 10.1128/aac.00727-26.
- PMCID: PMC13689056
Mancini S, et al.Antimicrob Agents Chemother. 2026.PMCID: PMC13689056 -
N-terminal lysine as a critical determinant of odilorhabdin susceptibility to inactivation by the self-resistance acetyltransferase OatA.
- Racine E, Lanois-Nouri A, Houard J, Pantel L, Givaudan A, Gualtieri M.
- Antimicrob Agents Chemother. 2026 Sep 16;70(10):e0074326. doi: 10.1128/aac.00743-26.
- PMCID: PMC13689418
Racine E, et al.Antimicrob Agents Chemother. 2026.PMCID: PMC13689418 -
Mechanistic blockade of RSV infection by a pre-F targeting single-domain antibody-Fc fusion protein.
- Liu S, Qiu X, Guo S, Wang L, Shen H, An M.
- Antimicrob Agents Chemother. 2026 Sep 16;70(10):e0054126. doi: 10.1128/aac.00541-26.
- PMCID: PMC13689173
Liu S, et al.Antimicrob Agents Chemother. 2026.PMCID: PMC13689173 -
High frequency of isavuconazole use over voriconazole for chronic pulmonary aspergillosis: a retrospective observational study on tolerability and therapeutic drug monitoring.
- Fama F, Conflitti C, Civati A, Cattaneo D, Torre A, Cossu MV, Borghetti S, Visigalli D, Vimercati S, Antinori S, Riva A, Gori A, Colaneri M, Schiuma M.
- Antimicrob Agents Chemother. 2026 Sep 16;70(10):e0089226. doi: 10.1128/aac.00892-26.
- PMCID: PMC13688943
Fama F, et al.Antimicrob Agents Chemother. 2026.PMCID: PMC13688943 -
In vivo efficacy of cefiderocol against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa carrying the AmpC E219K substitution.
- Rodríguez-Coello A, Outeda-García M, García-Pose A, Gonzalez-Pinto L, Báez-Barroso GA, Guijarro-Sánchez P, Muras A, Taltavull B, Fraile-Ribot P, Alonso-Garcia I, Oliver A, Vázquez-Ucha JC, Arca-Suárez J, Bou G, Beceiro A.
- Antimicrob Agents Chemother. 2026 Sep 16;70(10):e0072426. doi: 10.1128/aac.00724-26.
- PMCID: PMC13689382
Rodríguez-Coello A, et al.Antimicrob Agents Chemother. 2026.PMCID: PMC13689382 -
Escherichia coli with penicillin-binding protein 3 insertions: implications for newer β-lactam/β-lactamase inhibitor combinations.
- Pitout JDD, Peirano G, Matsumura Y, Kock M, Chen L.
- Antimicrob Agents Chemother. 2026 Sep 16;70(10):e0107726. doi: 10.1128/aac.01077-26.
- PMCID: PMC13689002
Pitout JDD, et al.Antimicrob Agents Chemother. 2026.PMCID: PMC13689002 -
Efficacy of quabodepistat alone and in combination with delamanid and bedaquiline against Mycobacterium tuberculosis in an NHP model evaluated by [18F] FDG PET/CT and bacterial burden.
- Via LE, Sarathy J, Weiner DM, Greenstein T, Zimmerman M, Abdi A, Fleegle JD, Gomez F, Kaya F, Piazza MK, Vatthauer A, Sloan BY, Repoli KM, Walker AM, Woodcock MJ, Egbelowo O, Gausi K, Boshoff HIM, Liu Y, Chadalavada D, Aldridge BB, Dartois V, Barry CE 3rd.
- Antimicrob Agents Chemother. 2026 Sep 16;70(10):e0028026. doi: 10.1128/aac.00280-26.
- PMCID: PMC13688883
Via LE, et al.Antimicrob Agents Chemother. 2026.PMCID: PMC13688883 -
Effectiveness of benznidazole in the treatment of Chagas disease in children and adults: a long-term retrospective cohort study.
- Rabinovich A, Cruz C, Moscatelli G, Moroni S, González N, Ramirez JC, Garcia-Bournissen F, Ballering G, Freilij H, Altcheh J.
- Antimicrob Agents Chemother. 2026 Sep 11;70(10):e0020326. doi: 10.1128/aac.00203-26.
- PMCID: PMC13689171
Rabinovich A, et al.Antimicrob Agents Chemother. 2026.PMCID: PMC13689171 -
Effectiveness and safety of cefazolin vs antistaphylococcal penicillins for methicillin-susceptible Staphylococcus aureus bacteremia: a multicenter real-world evaluation using the international TriNetX database.
- Ramsamy N, Simon M, Adam I, Hernandez G, Williford S, Denquin O, Pulcini C, Thilly N, Lefèvre B.
- Antimicrob Agents Chemother. 2026 Sep 11;70(10):e0176525. doi: 10.1128/aac.01765-25.
- PMCID: PMC13688797
Ramsamy N, et al.Antimicrob Agents Chemother. 2026.PMCID: PMC13688797 -
Development of a dosing algorithm integrating pharmacogenetic markers and inflammation for individualization of initial voriconazole maintenance doses.
- Gautier-Veyret E, Giannoni O, Manceau M, Arrive C, Klomp S, Roustit M, Lamoureux F, Hennart B, Solas C, Baklouti S, Verstuyft C, Boglione-Kerrien C, Swen JJ, Pallet N, Veringa A, Alffenaar JWC, Yamada T, Naito T, Stanke-Labesque F, Khouri C; Therapeutic Drug Monitoring and Personalization Treatment group of the French Society of Pharmacology and Therapeutics and the French-Speaking Network of Pharmacogenetics (RNPGx).
- Antimicrob Agents Chemother. 2026 Sep 11;70(10):e0027826. doi: 10.1128/aac.00278-26.
- PMCID: PMC13689213
Gautier-Veyret E, et al.Antimicrob Agents Chemother. 2026.PMCID: PMC13689213